The company maintains close ties with clinical research institutions and scientific research academies, forming a research team focused on the prevention and treatment of cardiovascular and cerebrovascular diseases. Always adhering to continuous innovation as a strategic approach to enhance its core competitiveness, the company has developed a research culture of innovative development tailored to public health needs and established a corresponding research management system, creating a favorable innovative atmosphere for researchers. In collaboration with clinical research institutions, it has developed ischemic preconditioning training devices, opening up a new pathway for the prevention and treatment of cardiovascular and cerebrovascular diseases. The company has won numerous awards, including the Second Prize of National Scientific and Technological Progress, the First Prize of Scientific and Technological Progress awarded by the Ministry of Education, the Stroke Innovation Award from the United States, and the Medical Industry Development and Innovation Award. It holds invention patents in China, the United States, and Japan. Due to its simple training method, lack of surgical risk, and low recurrence rate, especially for elderly patients and those intolerant to surgery, it provides a new and effective treatment method. It is considered one of the most promising preventive and therapeutic means for ischemic cardiovascular and cerebrovascular diseases.

The company maintains close ties with clinical research institutions and scientific research academies, forming a research team focused on the prevention and treatment of cardiovascular and cerebrovascular diseases. Always adhering to continuous innovation as a strategic approach to enhance its core competitiveness, the company has developed a research culture of innovative development tailored to public health needs and established a corresponding research management system, creating a favorable innovative atmosphere for researchers. In collaboration with clinical research institutions, it has developed ischemic preconditioning training devices, opening up a new pathway for the prevention and treatment of cardiovascular and cerebrovascular diseases. The company has won numerous awards, including the Second Prize of National Scientific and Technological Progress, the First Prize of Scientific and Technological Progress awarded by the Ministry of Education, the Stroke Innovation Award from the United States, and the Medical Industry Development and Innovation Award. It holds invention patents in China, the United States, and Japan. Due to its simple training method, lack of surgical risk, and low recurrence rate, especially for elderly patients and those intolerant to surgery, it provides a new and effective treatment method. It is considered one of the most promising preventive and therapeutic means for ischemic cardiovascular and cerebrovascular diseases.